Complement inhibitor factor H expressed by breast cancer cells differentiates CD14⁺ human monocytes into immunosuppressive macrophages

References

• Yona S, Kim K-W, Wolf Y, Mildner A, Varol D, Breker M, Strauss-Ayali D, Viukov S, Guilliams M, Misharin A, et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013;38(1):79–15. doi:10.1016/j.immuni.2012.12.001.
   PubMed Web of Science ®Google Scholar
• Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE, Ivanov S, Duan Q, Bala S, Condon T, et al. Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity. 2013;39(3):599–610. doi:10.1016/j.immuni.2013.08.007.
   PubMed Web of Science ®Google Scholar
• Liu K, Waskow C, Liu X, Yao K, Hoh J, Nussenzweig M. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat Immunol. 2007;8(6):578–583. doi:10.1038/ni1462.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889–896. doi:10.1038/ni.1937.
   PubMed Web of Science ®Google Scholar
• MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 1997;15:323–350. doi:10.1146/annurev.immunol.15.1.323.
   PubMed Web of Science ®Google Scholar
• Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014;6:13.
   PubMedGoogle Scholar
• Taylor PR, Pickering MC, Kosco-Vilbois MH, Walport MJ, Botto M, Gordon S, Martinez-Pomares L. The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues. Eur J Immunol. 2002;32(7):1883–1896. doi:10.1002/1521-4141(200207)32:7<1883::AID-IMMU1888>3.0.CO;2-8.
   Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton J, Ivashkiv L, Lawrence T. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996;56:4625–4629.
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol. 2009;182(8):4499–4506. doi:10.4049/jimmunol.0802740.
   PubMed Web of Science ®Google Scholar
• Conklin MW, Keely PJ. Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers. Cell Adh Migr. 2012;6(3):249–260. doi:10.4161/cam.20567.
   PubMed Web of Science ®Google Scholar
• Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623–630. doi:10.1189/jlb.1107762.
   PubMed Web of Science ®Google Scholar
• Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer. 2012;12:306. doi:10.1186/1471-2407-12-306.
   PubMed Web of Science ®Google Scholar
• Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjorge L, Butzow R, Zipfel PF, Meri S. Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. Br J Cancer. 2002;87(10):1119–1127. doi:10.1038/sj.bjc.6600614.
   PubMed Web of Science ®Google Scholar
• Ajona D, Castano Z, Garayoa M, Zudaire E, Pajares MJ, Martinez A, Cuttitta F, Montuenga LM, Pio R. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res. 2004;64(17):6310–6318. doi:10.1158/0008-5472.CAN-03-2328.
   PubMed Web of Science ®Google Scholar
• Ohtsuka H, Imamura T, Matsushita M, Tanase S, Okada H, Ogawa M, Kambara T. Thrombin generates monocyte chemotactic activity from complement factor H. Immunology. 1993;80:140–145.
   PubMed Web of Science ®Google Scholar
• Hartung HP, Hadding U, Bitter-Suermann D, Gemsa D. Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H. Clin Exp Immunol. 1984;56:453–458.
   PubMed Web of Science ®Google Scholar
• Calippe B, Augustin S, Beguier F, Charles-Messance H, Poupel L, Conart J-B, Hu SJ, Lavalette S, Fauvet A, Rayes J. Complement factor H inhibits CD47-mediated resolution of inflammation. Immunity. 2017;46(2):261–272. doi:10.1016/j.immuni.2017.01.006.
   PubMed Web of Science ®Google Scholar
• Martin M, Leffler J, Smolag KI, Mytych J, Bjork A, Chaves LD, Alexander JJ, Quigg RJ, Blom AM. Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ. 2016;23(5):903–911. doi:10.1038/cdd.2015.164.
   PubMed Web of Science ®Google Scholar
• Blom AM, Kask L, Dahlback B. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. Mol Immunol. 2003;39(10):547–556. doi:10.1016/S0161-5890(02)00213-4.
   PubMed Web of Science ®Google Scholar
• Laurell CB, Dahlqvist I, Persson U. The use of thiol-disulphide exchange chromatography for the automated isolation of alpha 1-antitrypsin and other plasma proteins with reactive thiol groups. J Chromatogr. 1983;278(1):53–61. doi:10.1016/S0378-4347(00)84755-6.
   PubMed Web of Science ®Google Scholar
• Olivar R, Luque A, Cardenas-Brito S, Naranjo-Gomez M, Blom AM, Borras FE, Rodriguez de Córdoba S, Zipfel PF, Aran JM. The complement inhibitor factor h generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells. J Immunol. 2016;196(10):4274–4290. doi:10.4049/jimmunol.1500455.
   PubMed Web of Science ®Google Scholar
• Schmidt CQ, Herbert AP, Kavanagh D, Gandy C, Fenton CJ, Blaum BS, Lyon M, Uhrín D, Barlow PN. A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol. 2008;181(4):2610–2619. doi:10.4049/jimmunol.181.4.2610.
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034. doi:10.1186/gb-2002-3-7-research0034.
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31(4):e15. doi:10.1093/nar/gng015.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995;57:289–300.
   Web of Science ®Google Scholar
• Luo W, Friedman MS, Shedden K, Hankenson KD, Woolf PJ. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics. 2009;10:161. doi:10.1186/1471-2105-10-161.
   PubMed Web of Science ®Google Scholar
• Svensson KJ, Christianson HC, Kucharzewska P, Fagerstrom V, Lundstedt L, Borgquist S, et al. Chondroitin sulfate expression predicts poor outcome in breast cancer. Int J Oncol. 2011;39(6):1421–1428. doi:10.3892/ijo.2011.1164.
   PubMed Web of Science ®Google Scholar
• Borgquist S, Jogi A, Ponten F, Ryden L, Brennan DJ, Jirstrom K. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Breast Cancer Res. 2008;10(5):R79. doi:10.1186/bcr2146.
   PubMed Web of Science ®Google Scholar
• Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirstrom K. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. J Clin Pathol. 2008;61(2):197–203. doi:10.1136/jcp.2006.040378.
   PubMed Web of Science ®Google Scholar
• Bayik D, Tross D, Haile LA, Verthelyi D, Klinman DM. Regulation of the maturation of human monocytes into immunosuppressive macrophages. Blood Adv. 2017;1(26):2510–2519. doi:10.1182/bloodadvances.2017011221.
   PubMed Web of Science ®Google Scholar
• EMMMFJVJA ATEN. Measurement of co‐localization of objects in dual‐colour confocal images. J Microsc. 1993;169:375–382. doi:10.1111/j.1365-2818.1993.tb03313.x.
   PubMed Web of Science ®Google Scholar
• Ferreira VP, Herbert AP, Hocking HG, Barlow PN, Pangburn MK. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol. 2006;177(9):6308–6316. doi:10.4049/jimmunol.177.9.6308.
   PubMed Web of Science ®Google Scholar
• Oppermann M, Manuelian T, Jozsi M, Brandt E, Jokiranta TS, Heinen S, Meri S, Skerka C, Gotze O, Zipfel PF. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol. 2006;144(2):342–352. doi:10.1111/cei.2006.144.issue-2.
   PubMed Web of Science ®Google Scholar
• Kotyza J. Interleukin-8 (CXCL8) in tumor associated non-vascular extracellular fluids: its diagnostic and prognostic values. A review Int J Biol Markers. 2012;27(3):169–178. doi:10.5301/JBM.2012.9261.
   PubMed Web of Science ®Google Scholar
• Parry RV, Chemnitz JM, Frauwirth KA, Lanfranco AR, Braunstein I, Kobayashi SV, Linsley PS, Thompson CB, Riley JL. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol. 2005;25(21):9543–9553. doi:10.1128/MCB.25.21.9543-9553.2005.
   PubMed Web of Science ®Google Scholar
• Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J. GOBO: gene expression-based outcome for breast cancer online. PLoS One. 2011;6(3):e17911. doi:10.1371/journal.pone.0017911.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F. A pathology atlas of the human cancer transcriptome. Science. 2017;357:6352. doi:10.1126/science.aan2507.
   Web of Science ®Google Scholar
• Lundgren S, Karnevi E, Elebro J, Nodin B, Karlsson MCI, Eberhard J, Leandersson K, Jirström K. The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype. J Transl Med. 2017;15(1):152. doi:10.1186/s12967-017-1256-y.
   PubMed Web of Science ®Google Scholar
• Aguirre-Gamboa R, Gomez-Rueda H, Martinez-Ledesma E, Martinez-Torteya A, Chacolla-Huaringa R, Rodriguez-Barrientos A, Tamez-Peña JG, Treviño V. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PLoS One. 2013;8(9):e74250. doi:10.1371/journal.pone.0074250.
   PubMed Web of Science ®Google Scholar
• Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, Giuliano A, Baumgartner K, Herrick J, Wolff RK. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One. 2013;8(5):e63165. doi:10.1371/journal.pone.0063165.
   PubMed Web of Science ®Google Scholar
• Krakowiak MS, Noto JM, Piazuelo MB, Hardbower DM, Romero-Gallo J, Delgado A, Chaturvedi R, Correa P, Wilson KT, Peek RM, et al. Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization. Oncogene. 2015;34(14):1865–1871. doi:10.1038/onc.2014.135.
   PubMed Web of Science ®Google Scholar
• Huang WC, Sala-Newby GB, Susana A, Johnson JL, Newby AC. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kappaB. PLoS One. 2012;7(8):e42507. doi:10.1371/journal.pone.0042507.
   PubMed Web of Science ®Google Scholar
• Choi SC, Kim KD, Kim JT, Oh SS, Yoon SY, Song EY, Lee HG, Choe Y-K, Choi I, Lim J-S, et al. NDRG2 is one of novel intrinsic factors for regulation of IL-10 production in human myeloid cell. Biochem Biophys Res Commun. 2010;396(3):684–690. doi:10.1016/j.bbrc.2010.04.162.
   PubMed Web of Science ®Google Scholar
• Li M, Lai X, Zhao Y, Zhang Y, Li M, Li D, Kong J, Zhang Y, Jing P, Li H, et al. Loss of NDRG2 in liver microenvironment inhibits cancer liver metastasis by regulating tumor associate macrophages polarization. Cell Death Dis. 2018;9(2):248. doi:10.1038/s41419-018-0284-8.
   PubMed Web of Science ®Google Scholar
• Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol. 2006;177(6):3520–3524. doi:10.4049/jimmunol.177.6.3520.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Baban B, Chandler P, Marshall B, Jhaver K, Hansen A, Koni PA, Iwashima M, Munn DH. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol. 2003;171(4):1652–1655. doi:10.4049/jimmunol.171.4.1652.
   PubMed Web of Science ®Google Scholar
• Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5(8):641–654. doi:10.1038/nri1668.
   PubMed Web of Science ®Google Scholar
• Thomas AC, Mattila JT. “Of mice and men”: arginine metabolism in macrophages. Front Immunol. 2014;5:479. doi:10.3389/fimmu.2014.00479.
   PubMed Web of Science ®Google Scholar
• Bertucci F, Goncalves A. Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1. Curr Oncol Rep. 2017;19(10):64. doi:10.1007/s11912-017-0627-0.
   PubMed Web of Science ®Google Scholar
• Wang C, Thudium KB, Han M, Wang X-T, Huang H, Feingersh D, Garcia C, Wu Y, Kuhne M, Srinivasan M. In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates. Cancer Immunol Res. 2014;2(9):846–856. doi:10.1158/2326-6066.CIR-14-0040.
   PubMed Web of Science ®Google Scholar
• Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4(7):540–550. doi:10.1038/nrc1388.
   PubMed Web of Science ®Google Scholar
• Alfaro C, Sanmamed MF, Rodriguez-Ruiz ME, Teijeira A, Onate C, Gonzalez A, Ponz M, Schalper KA, Pérez-Gracia JL, Melero I, et al. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treat Rev. 2017;60:24–31. doi:10.1016/j.ctrv.2017.08.004.
   PubMed Web of Science ®Google Scholar
• Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, Zlabinger GJ, Stulnig TM. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond). 2007;31(9):1420–1428. doi:10.1038/sj.ijo.0803632.
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, Hugol D, Basdevant A, Aissat A, Guerre-Millo M, Clément K. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab. 2009;94(11):4619–4623. doi:10.1210/jc.2009-0925.
   PubMed Web of Science ®Google Scholar
• Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Moran-Salvador E, Martinez-Clemente M, Arroyo V, Clària J. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. J Immunol. 2011;187(10):5408–5418. doi:10.4049/jimmunol.1100225.
   PubMed Web of Science ®Google Scholar
• Svensson-Arvelund J, Mehta RB, Lindau R, Mirrasekhian E, Rodriguez-Martinez H, Berg G, Lash GE, Jenmalm MC, Ernerudh J. The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol. 2015;194(4):1534–1544. doi:10.4049/jimmunol.1401536.
   PubMed Web of Science ®Google Scholar
• Dupasquier M, Stoitzner P, Wan H, Cerqueira D, van Oudenaren A, Voerman JS, Denda-Nagai K, Irimura T, Raes G, Romani N. The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling. J Leukoc Biol. 2006;80(4):838–849. doi:10.1189/jlb.1005564.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Evers S, Roeder D, Parlow AF, Risteli J, Risteli L, et al. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science. 2002;295(5561):1898–1901. doi:10.1126/science.1069540.
   PubMed Web of Science ®Google Scholar
• Shabo I, Stal O, Olsson H, Dore S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008;123(4):780–786. doi:10.1002/ijc.23527.
   PubMed Web of Science ®Google Scholar
• Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 2012;189(7):3508–3520. doi:10.4049/jimmunol.1200662.
   PubMed Web of Science ®Google Scholar
• Haapasalo K, Jarva H, Siljander T, Tewodros W, Vuopio-Varkila J, Jokiranta TS. Complement factor H allotype 402H is associated with increased C3b opsonization and phagocytosis of Streptococcus pyogenes. Mol Microbiol. 2008;70(3):583–594. doi:10.1111/mmi.2008.70.issue-3.
   PubMed Web of Science ®Google Scholar
• Abdul-Aziz M, Tsolaki AG, Kouser L, Carroll MV, Al-Ahdal MN, Sim RB, Kishore U. Complement factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine response. Immunobiology. 2016;221(9):944–952. doi:10.1016/j.imbio.2016.05.011.
   PubMed Web of Science ®Google Scholar
• Kang YH, Urban BC, Sim RB, Kishore U. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells. Immunobiology. 2012;217(4):455–464. doi:10.1016/j.imbio.2011.10.008.
   PubMed Web of Science ®Google Scholar
• Wang FM, Song D, Pang Y, Song Y, Yu F, Zhao MH. The dysfunctions of complement factor H in lupus nephritis. Lupus. 2016;25(12):1328–1340. doi:10.1177/0961203316642307.
   PubMed Web of Science ®Google Scholar